Kolexia
Lotz Jean-Pierre Oncologie médicale
Lotz Jean-Pierre
Oncologie médicale
Hôpital Tenon
Paris, France
165 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs embryonnaires et germinales Tumeurs de l'ovaire Tumeurs du sein Maladie trophoblastique gestationnelle Métastase tumorale Sarcomes Récidive tumorale locale COVID-19 Carcinome épithélial de l'ovaire

Collaborateurs

Voir plus
Gligorov Joseph
Gligorov Joseph
Hôpital Tenon, Paris, France
You Benoit
You Benoit
Hôpital Lyon Sud, Pierre-Bénite, France
Selle Frederic
Selle Frederic
Institut Caroline Malvesin, Paris, France
Golfier Francois
Golfier Francois
Hôpital Lyon Sud, Pierre-Bénite, France

Industries

Voir plus
Novartis
5 collaboration(s)
Dernière en 2022
A+A
4 collaboration(s)
Dernière en 2021
MundiPharma
3 collaboration(s)
Dernière en 2020
MSD
2 collaboration(s)
Dernière en 2023

Dernières activités

Voir plus
AcSé: Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types
Essai Clinique (Unicancer)   26 février 2024
ATALANTE: A Randomized, Double-blinded, Phase III Study of Atezolizumab Versus Placebo in Patients With Late Relapse of Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer Treated by Platinum-based Chemotherapy and Bevacizumab
Essai Clinique (Roche)   02 janvier 2024
Updated progression-free survival and final overall survival with maintenance olaparib plus bevacizumab according to clinical risk in patients with newly diagnosed advanced ovarian cancer in the phase III PAOLA-1/ENGOT-ov25 trial.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society   21 décembre 2023
Impact of molecular genotyping on the diagnosis and treatment of human chorionic gonadotropin-producing tumors.
Journal of gynecology obstetrics and human reproduction   29 novembre 2023
793P Strong relationships between the CA-125 KELIM score and the tumor biological effects after neo-adjuvant chemotherapy in advanced ovarian cancer patients: CHIVA trial (GINECO)
Abstract Book of the ESMO Congress 2023, 20 - 24 October 2023.   01 octobre 2023
Multiple pregnancy with complete hydatidiform mole and coexisting normal fetus in a retrospective cohort of 141 patients.
American journal of obstetrics and gynecology   16 septembre 2023
CHIVA: Randomized Double Blind Placebo-controlled Phase II Trial of Vargatef® (Nintedanib) in Addition to First Line Chemotherapy With Interval Debulking Surgery in Patients With Adenocarcinoma of the Ovary, the Fallopian Tube or Serous Adenocarcinoma of the Peritoneum
Essai Clinique (ARCAGY/ GINECO GROUP)   05 septembre 2023
Atezolizumab Combined With Bevacizumab and Platinum-Based Therapy for Platinum-Sensitive Ovarian Cancer: Placebo-Controlled Randomized Phase III ATALANTE/ENGOT-ov29 Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology   29 août 2023
Morbidity, mortality, and prognostic factors in gestational trophoblastic neoplasia with liver metastasis.
Journal of gynecology obstetrics and human reproduction   25 juillet 2023
Pembrolizumab in patients with rare and ultra-rare sarcomas (AcSé Pembrolizumab): analysis of a subgroup from a non-randomised, open-label, phase 2, basket trial.
The Lancet. Oncology   07 juillet 2023